These tumors primarily include isocitrate dehydrogenase (IDH)-mutant astrocytomas and oligodendrogliomas with combined IDH mutation and 1p/19q co-deletion, which correspond to WHO grade 2 lesions within the spectrum of adult-type diffuse gliomas [1,2]. This evidence concerns the gene IDH1 and oligodendroglioma.